title: Capecitabine-induced inflammation of actinic keratosis: case report and literature review.
authors.forename: Monica
authors.initials: M
authors.lastname: Stanciu
authors.forename: Nicolas
authors.initials: N
authors.lastname: Aubut
authors.forename: Eric
authors.initials: E
authors.lastname: Gagné
authors.forename: Marie-Marthe
authors.initials: MM
authors.lastname: Thibeault
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000284:Administration, Oral; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004817:Epidermis / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005500:Follow-Up Studies; D006801:Humans; D055623:Keratosis, Actinic / Q000139:chemically induced* / Q000175:diagnosis; D011355:Prodrugs; D012004:Rectal Neoplasms / Q000188:drug therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D011355:Prodrugs; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil